Resmed Will Report Fiscal 2027 Earnings on October 29

The San Diego-based medical company is scheduled to announce its first quarter financial results in late October.

Updated on Oct. 1, 2026 in Public Companies

Isometric editorial illustration of a medical breathing valve on a pedestal, representing the corporate medical device sector. — Resmed is scheduled to release its fiscal 2027 first quarter financial results on October 29, 2026, following the close of the market. AI Illustration. Upload story photo >

Live Poll

Do you generally trust public earnings reports to accurately reflect a company's future performance?

Resmed will release its fiscal year 2027 first quarter financial results after the New York Stock Exchange closes on October 29, 2026. Management will host a live webcast to discuss the company's financial and operational performance.

Why it matters

The upcoming earnings call provides investors with a detailed look at the financial health and operational trajectory of the San Diego-based medical device manufacturer.

Resmed products are currently utilized across 140 countries worldwide. The company maintains listings on both the New York Stock Exchange and the Australian Securities Exchange.

The players

Resmed

Resmed is a San Diego-based medical technology company that specializes in cloud-connected devices for treating sleep apnea and other respiratory conditions.

The details

Company leadership will discuss results exclusively through a webcast hosted on their investor relations website, as live phone access for the event is not supported. Following the live session, a recorded replay will be accessible online and via phone.

October 29, 2026, 1:30 p.m. PT: Live earnings webcast begins.
October 29, 2026, after 3:30 p.m. PT: Webcast replay becomes available.
November 12, 2026: Phone replay access concludes.

Market Landscape

The upcoming earnings announcement aligns with the standard quarterly reporting cycle required for companies traded on the New York Stock Exchange. This event positions Resmed to provide updated guidance to shareholders amid the broader competitive landscape for medical devices.

Shareholders and market analysts can access the financial results and management commentary directly through the company website. Investors should note that the live call does not offer phone-in access, making the digital portal the primary resource for participation.

The takeaway

Interested parties should ensure they have reliable internet access to join the webcast, as phone-in participation is not an option. Monitoring the official investor portal remains the most effective way to track corporate performance and shifts in market positioning.